Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
Qian‐Fang Meng(Shenzhen Bay Laboratory), Lang Rao(Shenzhen Metro (China)), Lujie Liu(Henan Agricultural University), Yuanwei Pan(National University of Singapore), Jialin Lai(University of Hong Kong), Zhida Liu(The University of Texas Southwestern Medical Center), Chunbo Dong(Shanxi Academy of Building Research), Xiaoyuan Chen(Agency for Science, Technology and Research), Yuyue Zhao(Southern Medical University), Guang‐Tao Yu(Wuhan University)
Cited by 118
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.3k
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
|Nature Communications|2020|373
Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
|Advanced Materials|2020|278
Supramolecular Polymerization‐Induced Nanoassemblies for Self‐Augmented Cascade Chemotherapy and Chemodynamic Therapy of Tumor
|Angewandte Chemie International Edition|2021|252